MSD & GSK only brought dishonor on NIP over their cervical cancer vaccines

The pharmaceutical companies which delayed the enforcement day to raise profits on the NIP project with cervical cancer vaccines did not earn substance, but only brought dishonor.

This is because the unit prices bid at the Public Procurement Service for the NIP on ‘Gardasil’ and ‘Cervarix’ did not go as the two companies wanted.

The Ministry of Health and Welfare announced to enforce the ‘Fir...